Our capabilities include:
Strategic planning
 | Message development |
 | Positioning |
 | Developing/implementing communications programs |
Investor/media relations
 | Contacting/building relationships with members of the financial and media communities |
Event planning
|
Writing/editing
 | Press releases |
 | Press kits |
 | Annual reports |
 | Corporate fact sheets |
 | Technology backgrounders |
 | SEC documents |
 | Technical documents |
 | Scientific manuscripts |
 | By-lined articles |
 | Web site content |
 | Corporate presentations |
 | Marketing materials |
|
Our areas of expertise include:
Technologies
 | Gene identification |
 | Functional genomics |
 | Nucleic acids |
 | Small-molecule drugs |
 | Monoclonal antibodies |
 | Soluble receptors |
 | Therapeutic proteins |
 | Cancer vaccines |
 | Gene therapy |
 | Cellular therapy |
|
Disease indications
 | Oncology |
 | Autoimmune diseases |
 | HIV/AIDS therapies and prophylaxis |
 | Cardiovascular disease |
 | Viral infectious diseases |
 | Genetic disorders |
 | Gastrointestinal disorders |
 | Coagulation and hemostasis |
Corporate issues
 | SEC disclosure/Reg FD |
 | Crisis management |
 | Image management |
 | Employee communications |
 | Outreach to patient advocacy groups |
|